Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Phio Pharmaceuticals ( (PHIO) ) just unveiled an announcement.
Phio Pharmaceuticals Corp. has announced that its 2025 Annual Meeting of Stockholders will be held on September 11, 2025, with stockholders of record on July 18, 2025, entitled to vote. The company has revised deadlines for stockholder proposals due to the meeting date being more than 30 days after the previous year’s meeting, with proposals needing to be submitted by July 17, 2025, to be considered for inclusion in proxy materials.
The most recent analyst rating on (PHIO) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Phio Pharmaceuticals stock, see the PHIO Stock Forecast page.
Spark’s Take on PHIO Stock
According to Spark, TipRanks’ AI Analyst, PHIO is a Neutral.
Phio Pharmaceuticals is struggling financially, with no revenue and consistent losses, significantly impacting its stock score. The technical indicators show mixed signals, with some short-term momentum but bearish long-term trends. The valuation is speculative due to negative earnings. The recent board appointment is a positive corporate event but has limited impact on overall financial health.
To see Spark’s full report on PHIO stock, click here.
More about Phio Pharmaceuticals
Average Trading Volume: 3,463,317
Technical Sentiment Signal: Sell
Current Market Cap: $11.52M
For an in-depth examination of PHIO stock, go to TipRanks’ Overview page.